Lloyd Y. Tani
No Rating Available
(Learn About Our Rating System)

Lloyd Y. Tani, MD

Languages spoken: Spanish, English

Lloyd Y. Tani, MD received both his undergraduate education and his medical degree from the University of California, Los Angeles. He received his pediatric and pediatric cardiology training from the Baylor College of Medicine and Texas Children’s Hospital. He is a Professor of Pediatrics and has been a member of the faculty of the University of Utah School of Medicine for nearly 30 years.

Dr. Tani’s clinical interests include general pediatric cardiology, rheumatic fever and heart disease, Kawasaki disease, pediatric valvular disease, and echocardiography. Dr. Tani’s research interests include rheumatic fever and heart disease, Kawasaki disease, quality improvement and clinical outcomes, and pediatric echocardiography.

Specialties

Board Certification

American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Cardiology)

Lloyd Y. Tani, MD received both his undergraduate education and his medical degree from the University of California, Los Angeles. He received his pediatric and pediatric cardiology training from the Baylor College of Medicine and Texas Children’s Hospital. He is a Professor of Pediatrics and has been a member of the faculty of the University of Utah School of Medicine for nearly 30 years.

Dr. Tani’s clinical interests include general pediatric cardiology, rheumatic fever and heart disease, Kawasaki disease, pediatric valvular disease, and echocardiography. Dr. Tani’s research interests include rheumatic fever and heart disease, Kawasaki disease, quality improvement and clinical outcomes, and pediatric echocardiography.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor (Clinical)
Academic Divisions Cardiology
Board Certification
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Cardiology)

Education history

Undergraduate Biology - University of California - Los Angeles (UCLA) A.B.
Professional Medical Medicine - University of California - Los Angeles (UCLA) M.D.
Residency Pediatrics - Baylor College of Medicine Resident
Chief Resident Pediatrics - Baylor College of Medicine Chief Resident
Fellowship Pediatric Cardiology - Baylor College of Medicine Fellow

Selected Publications

Journal Article

  1. Vossler JD, Eckhauser AW, Griffiths ER, Hobbs RD, Lambert LM, Tani LY, Parsons N, Habib RH, Jacobs JP, Jacobs ML, Husain S (2024). Impact of Atrioventricular Valve Intervention at Each Stage of Single Ventricle Palliation. World journal for pediatric & congenital heart surgery, 21501351241269924.
  2. Samayoa JC, Boucek D, McCarthy E, Riley M, Ou Z, Tani LY, Hoskoppal AK, Gray RG, Martin M (2022). Echocardiographic Assessment of Melody Versus Sapien Valves Following Transcatheter Pulmonary Valve Replacement. JACC. Cardiovascular interventions, 15(2), 165-175.
  3. Barfuss SB, Boucek DM, McFarland CA, Martin MH, Minich LL, Eckhauser AW, Ou Z, Gray RG, Tani L (2022). Short Term Left Ventricular Reverse Remodeling after Transcatheter Aortic Valve Replacement in Children. Journal of the American Society of Echocardiography, 35(10), 1077-1083.
  4. Robertson DM, Wright MA, Ostrander B, Tani L (2022). Child Neurology: Case Report of Lambl Excrescences in a Pediatric Patient With Multifocal Strokes. Neurology,
  5. Nathan M, Newburger JW, Bell M, Tang A, Gongwer R, Dunbar-Masterson C, Atz AM, Bacha E, Colan S, Gaynor JW, Kanter K, Levine JC, Ohye R, Pizarro C, Schwartz S, Shirali G, Tani L, Tweddell J, Gurvitz M, Pediatric Heart Network Investigator (2022). Development of the Residual Lesion Score for congenital heart surgery: the RAND Delphi methodology. Cardiology in the young, 1-14.
  6. Robinson DL, Ware AL, Sauer MC, Williams RV, Ou Z, Presson AP, Tani LY, Minich LL, Truong D (2021). Implications of Changing Z-Score Models for Coronary Artery Dimensions in Kawasaki Disease. Pediatric cardiology, 42(2), 432-441.
  7. Blaney MM, Williams RV, Areinamo IA, Sauer M, Tani LY, Ou Z, Minich LL, Truong D (2021). The impact of the American Heart Association guidelines on patients treated for incomplete Kawasaki disease. Cardiology in the young, 32(7), 1-5.
  8. Hogan WJ, Winter S, Pinto NM, Weng C, Sheng X, Conradt E, Wood J, Puchalski MD, Tani LY, Miller T (2018). Neurobehavioral evaluation of neonates with congenital heart disease: a cohort study. Developmental medicine and child neurology, 60(12), 1225-1231.
  9. Johnson JT, Wilkes JF, Menon SC, Tani LY, Weng HY, Marino BS, Pinto N (2018). Admission to dedicated pediatric cardiac intensive care units is associated with decreased resource use in neonatal cardiac surgery. The Journal of thoracic and cardiovascular surgery, 155(6), 2606-2614.e5.
  10. Yamauchi MSW, Puchalski MD, Weng HT, Pinto NM, Etheridge SP, Presson AP, Tani LY, Minich LL, Williams R (2018). Disease progression and variation in clinical practice for isolated bicuspid aortic valve in children. Congenital heart disease, 13(3), 432-439.
  11. Lo JY, Minich LL, Tani LY, Wilkes J, Ding Q, Menon S (2016). Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database). The American journal of cardiology, 118(11), 1636-1640.
  12. Margossian R, Chen S, Sleeper LA, Tani LY, Shirali G, Golding F, Selamet Tierney ES, Altmann K, Campbell MJ, Szwast A, Sharkey A, Radojewski E, Colan SD, Pediatric Heart Network Investigator (2015). The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent. Journal of the American Society of Echocardiography, 28(5), 549-558.e1.
  13. Johnson JT, Eckhauser AW, Pinto NM, Weng HY, Minich LL, Tani L (2015). Indications for intervention in asymptomatic children with chronic mitral regurgitation. Pediatric cardiology, 36(2), 417-22.
  14. Johnson JT, Tani LY, Puchalski MD, Bardsley TR, Byrne JL, Minich LL, Pinto N (2014). Admission to a dedicated cardiac intensive care unit is associated with decreased resource use for infants with prenatally diagnosed congenital heart disease. Pediatric cardiology, 35(8), 1370-8.
  15. Ware AL, Tani LY, Weng HY, Wilkes J, Menon S (2014). Resource utilization and outcomes of infective endocarditis in children. The Journal of pediatrics, 165(4), 807-12.e1.
  16. Truong DT, Tani LY, Minich LL, Burch PT, Bardsley TR, Menon S (2014). Factors associated with recoarctation after surgical repair of coarctation of the aorta by way of thoracotomy in young infants. Pediatric cardiology, 35(1), 164-70.
  17. McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon S (2013). Myocardial strain and strain rate in Kawasaki disease. European heart journal. Cardiovascular Imaging, 14(11), 1061-8.
  18. Gray RG, Tani LY, Weng HY, Puchalski M (2013). Long-term follow-up of neonatal coarctation and left-sided cardiac hypoplasia. The American journal of cardiology, 111(9), 1351-4.
  19. Ritter S, Tani LY, Etheridge SP, Williams RV, Craig JE, Minich L (2000). What is the yield of screening echocardiography in pediatric syncope?. Pediatrics, 105(5), E58.

Review

  1. Cox DA, Tani L (2020). Pediatric Infective Endocarditis: A Clinical Update. Pediatric clinics of North America, 67(5), 875-888.
  2. Williams RV, Minich LL, Tani L (2001). Pharmacological therapy for patients with Kawasaki disease. Paediatric drugs, 3(9), 649-60.